RareResearch.AI
← Back to atlas

F515S

Category 2 — Moderately DestabilizingUncertain significanceTransmembrane · predictedSource card
PhenylalanineSerine at position 515 · Transmembrane helix 7 · WFS1 (Wolframin)

Interactive 3D Structure

Wild-type reference
Wild-type F515 — hydrogen bond to A519
Fullscreen ↗
DynaMut2 mutant · F515S
Mutant S515 — polar contact to R517 lost (10 contacts lost)
Fullscreen ↗

Bond changes · DynaMut2 interaction analysis

10 lost0 gained10 preserved
Interaction typeWild-type partnerMutant partnerStatus
Hydrogen bondL511L511Preserved
Hydrogen bondL512L512Preserved
Hydrogen bondM518M518Preserved
Hydrogen bondA519A519Preserved
Polar contactL511L511Preserved
Polar contactL512L512Preserved
Polar contactY513Y513Preserved
Polar contactR517Lost
Polar contactM518M518Preserved
Polar contactA519A519Preserved
Aromatic / πY534Lost
Van der WaalsL511Lost
Van der WaalsY513Y513Preserved
Van der WaalsR517Lost
HydrophobicL511Lost
HydrophobicL512Lost
HydrophobicM518Lost
HydrophobicL531Lost
HydrophobicY534Lost
HydrophobicF538Lost

Lost / gained / preserved interatomic contacts at the variant residue, from the DynaMut2 (Arpeggio) interaction analysis of the wild-type and energy-minimized mutant structures.

Computational Predictions

DynaMut2 ΔΔG
-3.33kcal/mol
Destabilising — large
AlphaMissense
0.801
likely pathogenic
AlphaFold pLDDT
87
model confidence
Schema
Cat 2
Category 2 — Moderately Destabilizing
ΔΔG confidence: Reduced confidence · Transmembrane
  • transmembrane position; predictor benchmarked on soluble proteins

This variant sits in the transmembrane band. The stability value was computed with a predictor benchmarked on water-soluble proteins. Published benchmarks of ddG predictors on membrane proteins report correlation below 0.4. Treat the magnitude as unreliable and the sign as weak evidence only.

Do not rank this value against a variant from a different region on ΔΔG alone.

Clinical Evidence

ClinVar classificationUncertain significance
Review statuscriteria provided, single submitter
Associated conditions
Population frequency (gnomAD v4)Ultra-rare · AF 0.000068%
cDNA changec.1544T>C
ClinVar accessionVCV002000596
Last evaluated2022/06/28 00:00

Observed at very low frequency in gnomAD.

Classified for1★ unverified submission

ClinVar classifies this variant as Uncertain significance, but does not state what it is classified for. ClinVar records no condition for this variant. A classification without a phenotype and an inheritance mode cannot be read as a statement about Wolfram syndrome risk or severity.

  • Phenotype scope is interpretation of submitted records. The computed values on this card (AlphaMissense, DynaMut2 ΔΔG, pLDDT) are measurements of the model, not of a patient.
  • Presentation cannot be generalised from neighbouring variants: one nucleotide over can present very differently. Structural similarity supports a mechanistic hypothesis, never a phenotype claim.

Review status: 1★ single submitter. ClinVar "conditions" is the union of all submissions; 0–1★ entries are submitted conditions, not documented phenotypes.

Population frequency
Global (all ancestries)
AF 0.000068% · 1 / 1,459,868 alleles
Homozygotes
0

Every ancestry group with observed alleles falls below the reporting threshold (min 2 alleles, min 500 sampled) — too sparse to name a highest-frequency population.

No homozygotes reported in gnomAD v4. For a recessive allele this is expected and is not, on its own, evidence either way.

Ancestry groupAllele freq.AC / ANHom.Carrier est.
European (non-Finnish) · under-sampled0.000090%1 / 1,111,9900

Source: gnomAD r4, retrieved 2026-08-21. Values are allele frequencies. The carrier estimate is derived from the allele frequency (Hardy-Weinberg, ~2·AF) and is an approximation, not a published figure — where a published carrier frequency exists it outranks this column and is cited on the card.

Full Variant Card

WFS1 Wolframin — F515S Variant Card

Molecular Atlas Pilot · RareResearch.AI · Generated by wolfram-variant-card skill

Phenylalanine → Serine at position 515. Transmembrane helix 7. ClinVar Uncertain significance, AlphaMissense 0.801, DynaMut2 ΔΔG -3.33 kcal/mol (destabilising).


Identity

FieldValue
VariantF515S (p.Phenylalanine515Serine)
DNA changec.1544T>C
Gene · ProteinWFS1 · Wolframin (890 aa)
UniProtO76024 · WFS1_HUMAN
ClinVar accessionVCV002000596
Amino acid changePhenylalanine (F) → Serine (S)

Structural Context

FieldValue
AlphaFold modelAF-O76024-F1, v6
pLDDT at residue 51586.50 — well-folded
DomainTransmembrane helix 7
Position contextInside Transmembrane helix 7 · position 515 is bilayer-embedded
IDR flagNo — pLDDT above 50 threshold

UniProt features at this position:

(none catalogued)

Position 515 sits in a transmembrane helix (Transmembrane helix 7). Wolframin has eleven such helices anchoring it in the ER membrane; substitutions inside the bilayer-embedded segments can disrupt helix packing, lipid contacts, and the overall ER topology of the protein. The wild-type residue is large aromatic hydrophobic (phenylalanine); the mutant is small polar (serine — hydroxyl). The chemistry shift implies altered local packing, hydrogen-bonding, and/or electrostatics at this site.


Computational Predictions

AlphaMissense

FieldValue
am_pathogenicity0.8012
am_classlikely pathogenic
InterpretationLikely pathogenic (threshold 0.564)

DynaMut2

FieldValue
ΔΔG (kcal/mol)-3.33 (Destabilising)
Job ID178092116465
Result URLJob 178092116465 · retrieved 2026-06-08 — result self-hosted by RareResearch.AI (Biosig no longer serves this page)

Clinical Evidence

Inheritance and scope

Uncertain significance — phenotype scope not stated in ClinVar

ClinVar classifies this variant as Uncertain significance, but does not state what it is classified for. ClinVar records no condition for this variant. A classification without a phenotype and an inheritance mode cannot be read as a statement about Wolfram syndrome risk or severity.

Phenotype scope is interpretation of submitted records. The computed values on this card (AlphaMissense, DynaMut2 ΔΔG, pLDDT) are measurements of the model, not of a patient. Presentation cannot be generalised from neighbouring variants: one nucleotide over can present very differently. Structural similarity supports a mechanistic hypothesis, never a phenotype claim.

FieldValue
ClassificationUncertain significance
Review statuscriteria provided, single submitter
Last evaluated2022/06/28 00:00
InheritanceInheritance pattern not specified in ClinVar entry; WFS1 has both AD and AR presentations.
WFS1 variant landscapeF515S is 1 of ~326 pathogenic-spectrum variants in WFS1 (out of 2,243 catalogued in ClinVar)

(no conditions catalogued)


Research Path Decision Tree

ΔΔG < 2  + binding site affected   →  CATEGORY 3 — docking experiments
ΔΔG 2–4                            →  CATEGORY 2 — pharmacological chaperones
ΔΔG > 4                            →  CATEGORY 1 — gene therapy
pLDDT < 50                         →  CATEGORY 5 — IDR, experimental only
Stable fold + functional site hit  →  CATEGORY 4 — site-specific docking

Final Schema Categorization

Category 2 — Moderately Destabilizing

<strong>Category 2 — Moderately Destabilizing</strong><br/><br/>|ΔΔG|=3.33 in the 2–4 range. Pharmacological chaperone candidate.


Files in this folder

  • AF-O76024-F1-model_v6.pdb — AlphaFold structure
  • F515S_molstar_viewer.html — interactive 3D viewer (auto-highlights position 515 with ball-and-stick + neighbors within 5Å)
  • F515S_variant_card.md — this card (source of truth)
  • F515S_variant_card.html — styled printable card
  • F515S_dynamut2_summary.html — clean offline DynaMut2 result card
  • dynamut2_result.json — structured result data
  • dynamut2_result_page.html — local snapshot of the Biosig result page (asset URLs absolutized)
  • F515S_wildtype_interactions.pse / F515S_mutant_interactions.pse — PyMOL sessions

Generated by wolfram-variant-card skill · RareResearch.AI Molecular Atlas Every assumption documented. Every score sourced.

Therapeutic Strategy Handoff · prediction

Feed this card to Wolfram Intelligence

Download the F515S PDF below and upload it to Wolfram Intelligence to generate therapeutic-strategy proposals — guanidinium mimetics, sigma-1 agonist docking, NAC thiol-capping. NAC is already on the bench-testing list.

Download F515S PDF card ↓Strategies are AI-generated predictions, not validated therapeutics.